MetabolismACCUMULATENCT05647135
ImpACt of Very High Protein Content Enteral nUtrition Formulas on Critically Ill MUltipLe trAuma paTiEnts
An observational study of Metabolism and Trauma, run by Romanian Society for Enteral and Parenteral Nutrition at 1 site in Romania.
Trial summary
This prospective observational randomized study aims to determine energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with very high protein content and enteral nutrition formulas with normal protein content. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Metabolism, Trauma, Nutritional Deficiency
- What is being tested?
- Medical food
- How many people
- 70 participants
- Where
- 1 siteRomania
- Study dates
- 1 Mar 2023to 1 Dec 2024
- How long will I take part?
- 8 Weeks
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: Consecutive patients with multiple trauma intubated and mechanical ventilated, admitted to the intensive care unit (ICU)
Who may be able to join
- Adult patients (>18 yrs) admitted to the ICU
- Multiple trauma (Injury severity score > 18)
- Intubation and mechanical ventilation upon admission in ICU or during the first 24 hours of admission, for at least 48 h
Who cannot join
- Age < 18 years
- Pregnant women
- Patients not intubated or not mechanically ventilated or receiving only non-invasive ventilation
- Patients with enteral feeding contraindication 48 h after admission
- Patients with recent gastrointestinal surgical intervention
- Patients on chronic therapy with corticosteroids
Trial locations and contacts
1 site in 1 country.
Romania1 site, 1 recruiting
- Recruiting
Clinical Emergency Hospital of Bucharest
Bucharest
Ioana Grințescu, Professor, +40722329187, ioana.grintescu@rospen.ro
Cristian Cobilinschi, MD, PhD, +40765018776, cristian.cobilinschi@umfcd.ro
About this study
Official title: ImpACt of Very High Protein Content Enteral nUtrition Formulas on Protein Metabolism and Residual Gastric Volume in Critically Ill MUltipLe trAuma paTiEnts
This prospective observational randomized study aims to determine energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with very high protein content and enteral nutrition formulas with normal protein content.
- Differences regarding achieving protein and calorie daily targets when using enteral nutrition formulas with different protein content
- Differences regarding residual gastric volume when using enteral nutrition formulas with different protein content
- Differences regarding body composition when using enteral nutrition formulas with different protein content
Read the detailed description
ImpACt of very high protein Content enteral nUtrition formulas on protein metabolism and residual gastric volume in critically ill MUltipLe trAuma paTiEnts
- ACCUMULATE trial -
Background and rationale:
Despite an increased survival among critically ill patients, many of the ICU "survivors" may develop prolonged functional disabilities. It has already been proven that nutritional therapy is essential, considering that an adequate provision of calories and proteins may influence patients prognostic.
Multiple trauma patients are on a particular nutritional risk, since their high nitrogen demands and associated nutritional therapy challenges, caused by repeated surgical intervention or multiple imagistic procedures. Although nutritional therapy impact on mortality is still in debate, clear, positive results were obtained in decreasing ICU and hospital stay after adequate nutritional support.
According to ESPEN guideline on clinical nutrition in the ICU early enteral nutrition (within 48 h) should be initiated in order to assure an adequate calorie and protein intake. Beside optimal timing, the management of nutrition therapy in critically ill patients should also integrate the optimal route and caloric/protein targets.
Energy requirements monitoring through indirect calorimetry has been proposed as a standard-of-care method for critically ill patients, considering its proven superiority towards predictive equation.
Beyond calorie intake, proteins proved to play a central role in maintain lean body mass, healing wounds and supporting immune function.For multiple trauma patients it was reported that protein losses may reach 14 % of the total body stores, thus this type of patients are exposed to a particular increased risk of protein deficits. If calorie administration benefits from a proper monitoring tool, protein requirements are still based on predictive equation. The impact of protein administration is also lacking of direct measurements techniques. Lean body mass evaluation by ultrasound and computerized tomography has been reported to have a good correlation with hospital stay and pots-ICU functional capacity. Moreover muscle function evaluation through a hand-grip dynamometer was also tested with good results in patients with ARDS.
Source of administered protein may also influence nitrogen balance, considering that whey proteins (rich in leucine) promote a slower hydrolysis and allow a longer period for absorption.
Reaching the recommended goals is often impeded by gastric intolerance manifested through increased gastric volume residues. It has been already demonstrated that large gastric volume residues are associated with impaired absorption and an increased incidence of aspiration pneumonia.
Gastrointestinal dysfunction in multiple trauma patients admitted to the intensive care unit (ICU) is an important yet underrecognized consequence. There are various causes of gastrointestinal tract dysfunction mostly related to patients general health condition and to their diagnostics. Gastrointestinal failure may be induced by several factors like immunological, biological and mechanical barrier disruption and it may be manifested through stress ulceration, bacterial translocation, ileus, intra-abdominal hypertension, diarrhoea and constipation.
Whether residual gastric volume monitoring should be regularly performed has been extensively discussed. Although the results from some randomised trials which focused on monitoring gastric residual volume, did not find any difference in outcomes, this measurement was far for being abandoned. Moreover, gastric residual volume monitoring is still an essential component of enteral nutrition patient care.
Although several monitoring methods for gastric volume residue measurements were described, there is no generally accepted technique for daily use.
Objective:
This prospective observational randomized study aims to determine energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with very high protein content and enteral nutrition formulas with normal protein content.
Safety points:
- Clinical parameters - vomiting, diarrhoea
- Biochemical parameters - base excess, urea levels
- Daily gastric residual volume evaluation using ultrasound gastric antrum measurements after 24 hours of continuous enteral nutrition administration using both types of formulas;
Study population Consecutive patients with multiple trauma intubated and mechanical ventilated, admitted to the intensive care unit (ICU).
Sample size calculation Since the hypotheses of the study are exploratory, no formal sample size calculation has been performed. This prospective observational study aims to recruit>70 multiple trauma patients.
Randomization:
Simple randomization method will be used to assign subjects into two groups A and B.
Ethical considerations:
This study will be conducted in full conformity with the Declaration of Helsinki and Good Clinical Practices.
Local ethical committee approval will be asked before any patient will be included.
Considering that nutritional support has become a standard-of-care in every intensive care unit in the world, it is considered that this research is based on collecting data routinely available for every critically ill patient. Although no intervention is performed an informed consent will be provided.
Taking into account that the included patients are not able to provide informed consent at the time of recruitment (on ICU admission), a Power of Attorney or a Legal tutor will act as Consultee and will be asked to consent/decline participation to the study on legal behalf of the patient. If patients have Advance Decision Plan including participation in research studies the Plan will be respected and recruitment pursued/abandoned accordingly.
After regaining capacity, all patients will be asked to provide Informed Consent for using their personal data and will be given the possibility to:
Provide Informed Consent for the acute data and follow-up. Deny research participation and request destruction of acute data collected.
Study participant research data, which is for purposes of statistical analysis and scientific reporting, will be transmitted to the Data Manager and the Statistician of the study.
Expected impact of the study KNOWLEDGE The investigators aim to provide a detailed description of protein administration using two different types of enteral formulas. The main objectives of the study are to evaluate energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with different protein content. Nevertheless, the investigators want to provide data about the impact of these different enteral nutrition formulas on body composition as well as on functionality.
Regarding of the obtained data a change on local and national recommendation considering enteral nutrition in multiple trauma patients is to be expected.
Funding All the enteral nutrition products are donated by the Nutricia Global. No funding will be received for this study.
- Conditions
- Metabolism, Trauma, Nutritional Deficiency, Protein Malnutrition, Gastroparesis, Muscle Loss
- Being tested
- Medical food
- Keywords
- enteral nutrition, multiple trauma, energy target, protein target, body composition, gastric residual volume, enteral nutrition intolerance
- Medical subject headings
- Wounds and Injuries, Malnutrition, Kwashiorkor, Gastroparesis, Muscular Atrophy, Protein-Energy Malnutrition, Multiple Trauma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Medical foodOther
enteral formulas with different protein composition
| Study group | Role | What they receive |
|---|---|---|
| Group A | Group A - enteral formula with 6.3 g/100 ml protein Receives: Other: Medical food | |
| Group B | enteral formula with 10 g/100 ml protein Receives: Other: Medical food |
What is being measured
The primary outcome is the main question the study is designed to answer.
Calorie and protein target
Differences regarding achieving protein and calorie daily targets in grams per kilogram of body weight (g/kg BW) at day 5 of the intervention period and at day 10 when using enteral nutrition formulas with different protein content
Measured: on day 5 days
Calorie and protein target
Differences regarding achieving protein and calorie daily targets in grams per kilogram of body weight (g/kg BW) at day 5 of the intervention period and at day 10 when using enteral nutrition formulas with different protein content
Measured: on day 10
Secondary outcomes (18)
Ultrasound-guided assessment of gastric residual volume
Differences regarding residual gastric volume when using enteral nutrition formulas with different protein content.
Ultrasound assessment of gastric volume using a current model for GV assessment based on antral cross-sectional area (CSA) - GV (ml)1⁄427.0+14.6×right-lateral CSA (cm2)21.28×age (yr)
Measured: on day 5
Ultrasound-guided assessment of gastric residual volume
Differences regarding residual gastric volume when using enteral nutrition formulas with different protein content.
Ultrasound assessment of gastric volume using a current model for GV assessment based on antral cross-sectional area (CSA) - GV (ml)1⁄427.0+14.6×right-lateral CSA (cm2)21.28×age (yr)
Measured: on day 10
Muscle function
Muscle function evaluation using handgrip dynamometer after extubation and sedation cessation
Measured: 24 hours after extubation
Muscle function
Muscle function evaluation using handgrip dynamometer after extubation and sedation cessation
Measured: 5 days after extubation
Body composition - Fat-free body mass
Fat-free body mass assessment using bioelectrical impedance analysis
Measured: 24 hours after extubation
Body composition - Fat-free body mass
Fat-free body mass assessment using whole-body bioelectrical impedance
Measured: 5 days after extubation
Body composition - Total body water
Total body water assessment using whole-body bioelectrical impedance analysis
Measured: 24 hours after extubation
Body composition - Total body water
Total body water assessment using whole-body bioelectrical impedance analysis
Measured: 5 days after extubation
Body composition - Phase angle
Phase angle measurement using whole-body bioelectrical impedance analysis
Measured: 24 hours after extubation
Body composition - Phase angle
Phase angle measurement using whole-body bioelectrical impedance analysis
Measured: 5 days after extubation
Body composition - ultrasound
Quadriceps rectus femoris thickness thickness measured by B-mode ultrasonography
Measured: baseline (on admission/first 24 hours)
Body composition - ultrasound
Quadriceps rectus femoris thickness measured by B-mode ultrasonography
Measured: on day 5
Body composition - ultrasound
Quadriceps rectus femoris thickness measured by B-mode ultrasonography
Measured: on day 10
Body composition - ultrasound
Quadriceps rectus femoris thickness measured by B-mode ultrasonography
Measured: on day 15
Inflammation - CRP
Plasmatic levels of C-reactive protein
Measured: on day 5
Inflammation - CRP
Plasmatic levels of C-reactive protein
Measured: on day 10
Inflammation - prealbumin
Plasmatic levels of prealbumin
Measured: on day 5
Inflammation - prealbumin
Plasmatic levels of prealbumin
Measured: on day 10
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Dec 2022
- Study start1 Mar 2023
- Primary completion1 Dec 2024 (estimated)
- Study completion1 Dec 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for MetabolismStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 70 participants (estimated)
- Target duration
- 8 Weeks
Sponsor and investigators
- Lead sponsor
- Romanian Society for Enteral and Parenteral Nutrition
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Ioana Grintescu, MD, PhD, Study director, Romanian Society of Enteral and Parenteral Nutrition
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05647135
- Sponsor's protocol ID
- rospen9accumulate
- Acronym
- ACCUMULATE
- Status last verified
- Jul 2024
- First submitted
- 1 Nov 2022
- Last updated
- 22 Jul 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Data requests can be submitted by researchers in the field of clinical nutrition starting 9 months after article publication and the data will be made accessible for up to 3 years. Extensions will be considered on a case-by-case basis
Publications
van Zanten ARH, Petit L, De Waele J, Kieft H, de Wilde J, van Horssen P, Klebach M, Hofman Z. Very high intact-protein formula successfully provides protein intake according to nutritional recommendations in overweight critically ill patients: a double-blind randomized trial. Crit Care. 2018 Jun 12;22(1):156. doi: 10.1186/s13054-018-2070-5.
PubMed 29895309Singer P. Protein metabolism and requirements in the ICU. Clin Nutr ESPEN. 2020 Aug;38:3-8. doi: 10.1016/j.clnesp.2020.03.026. Epub 2020 May 31.
PubMed 32690175Tedeschi-Jockers F, Reinhold S, Hollinger A, Tuchscherer D, Kiss C, Gantner L, Ledergerber K, Zimmermann S, Scheuzger J, Huber J, Siegemund M. A new high protein-to-energy enteral formula with a whey protein hydrolysate to achieve protein targets in critically ill patients: a prospective observational tolerability study. Eur J Clin Nutr. 2022 Mar;76(3):419-427. doi: 10.1038/s41430-021-00956-9. Epub 2021 Jun 24.
PubMed 34168292Berger MM, Reintam-Blaser A, Calder PC, Casaer M, Hiesmayr MJ, Mayer K, Montejo JC, Pichard C, Preiser JC, van Zanten ARH, Bischoff SC, Singer P. Monitoring nutrition in the ICU. Clin Nutr. 2019 Apr;38(2):584-593. doi: 10.1016/j.clnu.2018.07.009. Epub 2018 Jul 20.
PubMed 30077342Yasuda H, Kondo N, Yamamoto R, Asami S, Abe T, Tsujimoto H, Tsujimoto Y, Kataoka Y. Monitoring of gastric residual volume during enteral nutrition. Cochrane Database Syst Rev. 2021 Sep 27;9(9):CD013335. doi: 10.1002/14651858.CD013335.pub2.
PubMed 34596901
Study at a glance
From the registry record, last updated by the sponsor on 22 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- ImpACt of Very High Protein Content Enteral nUtrition Formulas on Protein Metabolism and Residual Gastric Volume in Critically Ill MUltipLe trAuma paTiEnts
- ClinicalTrials.gov ID
- NCT05647135
- Acronym / sponsor ID
- ACCUMULATE / rospen9accumulate
- Conditions
- Metabolism, Trauma, Nutritional Deficiency, Protein Malnutrition, Gastroparesis, Muscle Loss
- Keywords
- enteral nutrition, multiple trauma, energy target, protein target, body composition, gastric residual volume, enteral nutrition intolerance
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 70 participants (estimated)
- Lead sponsor
- Romanian Society for Enteral and Parenteral NutritionUniversity, hospital or other
- Study start
- 1 Mar 2023 (actual)
- Primary completion
- 1 Dec 2024 (estimated)
- Study completion
- 1 Dec 2024 (estimated)
- First posted
- 12 Dec 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This prospective observational randomized study aims to determine energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with very high protein content and enteral nutrition formulas with normal protein content.
- Differences regarding achieving protein and calorie daily targets when using enteral nutrition formulas with different protein content
- Differences regarding residual gastric volume when using enteral nutrition formulas with different protein content
- Differences regarding body composition when using enteral nutrition formulas with different protein content
Detailed description
ImpACt of very high protein Content enteral nUtrition formulas on protein metabolism and residual gastric volume in critically ill MUltipLe trAuma paTiEnts
- ACCUMULATE trial -
Background and rationale:
Despite an increased survival among critically ill patients, many of the ICU "survivors" may develop prolonged functional disabilities. It has already been proven that nutritional therapy is essential, considering that an adequate provision of calories and proteins may influence patients prognostic.
Multiple trauma patients are on a particular nutritional risk, since their high nitrogen demands and associated nutritional therapy challenges, caused by repeated surgical intervention or multiple imagistic procedures. Although nutritional therapy impact on mortality is still in debate, clear, positive results were obtained in decreasing ICU and hospital stay after adequate nutritional support.
According to ESPEN guideline on clinical nutrition in the ICU early enteral nutrition (within 48 h) should be initiated in order to assure an adequate calorie and protein intake. Beside optimal timing, the management of nutrition therapy in critically ill patients should also integrate the optimal route and caloric/protein targets.
Energy requirements monitoring through indirect calorimetry has been proposed as a standard-of-care method for critically ill patients, considering its proven superiority towards predictive equation.
Beyond calorie intake, proteins proved to play a central role in maintain lean body mass, healing wounds and supporting immune function.For multiple trauma patients it was reported that protein losses may reach 14 % of the total body stores, thus this type of patients are exposed to a particular increased risk of protein deficits. If calorie administration benefits from a proper monitoring tool, protein requirements are still based on predictive equation. The impact of protein administration is also lacking of direct measurements techniques. Lean body mass evaluation by ultrasound and computerized tomography has been reported to have a good correlation with hospital stay and pots-ICU functional capacity. Moreover muscle function evaluation through a hand-grip dynamometer was also tested with good results in patients with ARDS.
Source of administered protein may also influence nitrogen balance, considering that whey proteins (rich in leucine) promote a slower hydrolysis and allow a longer period for absorption.
Reaching the recommended goals is often impeded by gastric intolerance manifested through increased gastric volume residues. It has been already demonstrated that large gastric volume residues are associated with impaired absorption and an increased incidence of aspiration pneumonia.
Gastrointestinal dysfunction in multiple trauma patients admitted to the intensive care unit (ICU) is an important yet underrecognized consequence. There are various causes of gastrointestinal tract dysfunction mostly related to patients general health condition and to their diagnostics. Gastrointestinal failure may be induced by several factors like immunological, biological and mechanical barrier disruption and it may be manifested through stress ulceration, bacterial translocation, ileus, intra-abdominal hypertension, diarrhoea and constipation.
Whether residual gastric volume monitoring should be regularly performed has been extensively discussed. Although the results from some randomised trials which focused on monitoring gastric residual volume, did not find any difference in outcomes, this measurement was far for being abandoned. Moreover, gastric residual volume monitoring is still an essential component of enteral nutrition patient care.
Although several monitoring methods for gastric volume residue measurements were described, there is no generally accepted technique for daily use.
Objective:
This prospective observational randomized study aims to determine energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with very high protein content and enteral nutrition formulas with normal protein content.
Safety points:
- Clinical parameters - vomiting, diarrhoea
- Biochemical parameters - base excess, urea levels
- Daily gastric residual volume evaluation using ultrasound gastric antrum measurements after 24 hours of continuous enteral nutrition administration using both types of formulas;
Study population Consecutive patients with multiple trauma intubated and mechanical ventilated, admitted to the intensive care unit (ICU).
Sample size calculation Since the hypotheses of the study are exploratory, no formal sample size calculation has been performed. This prospective observational study aims to recruit>70 multiple trauma patients.
Randomization:
Simple randomization method will be used to assign subjects into two groups A and B.
Ethical considerations:
This study will be conducted in full conformity with the Declaration of Helsinki and Good Clinical Practices.
Local ethical committee approval will be asked before any patient will be included.
Considering that nutritional support has become a standard-of-care in every intensive care unit in the world, it is considered that this research is based on collecting data routinely available for every critically ill patient. Although no intervention is performed an informed consent will be provided.
Taking into account that the included patients are not able to provide informed consent at the time of recruitment (on ICU admission), a Power of Attorney or a Legal tutor will act as Consultee and will be asked to consent/decline participation to the study on legal behalf of the patient. If patients have Advance Decision Plan including participation in research studies the Plan will be respected and recruitment pursued/abandoned accordingly.
After regaining capacity, all patients will be asked to provide Informed Consent for using their personal data and will be given the possibility to:
Provide Informed Consent for the acute data and follow-up. Deny research participation and request destruction of acute data collected.
Study participant research data, which is for purposes of statistical analysis and scientific reporting, will be transmitted to the Data Manager and the Statistician of the study.
Expected impact of the study KNOWLEDGE The investigators aim to provide a detailed description of protein administration using two different types of enteral formulas. The main objectives of the study are to evaluate energy, protein intake and gastrointestinal tolerance while using enteral nutrition formulas with different protein content. Nevertheless, the investigators want to provide data about the impact of these different enteral nutrition formulas on body composition as well as on functionality.
Regarding of the obtained data a change on local and national recommendation considering enteral nutrition in multiple trauma patients is to be expected.
Funding All the enteral nutrition products are donated by the Nutricia Global. No funding will be received for this study.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 8 Weeks
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group A | – | Other: Medical foodGroup A - enteral formula with 6.3 g/100 ml protein |
| Group B | – | Other: Medical foodenteral formula with 10 g/100 ml protein |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Consecutive patients with multiple trauma intubated and mechanical ventilated, admitted to the intensive care unit (ICU)
Key inclusion criteria (3 listed)
- Adult patients (>18 yrs) admitted to the ICU
- Multiple trauma (Injury severity score > 18)
- Intubation and mechanical ventilation upon admission in ICU or during the first 24 hours of admission, for at least 48 h
Key exclusion criteria (6 listed)
- Age < 18 years
- Pregnant women
- Patients not intubated or not mechanically ventilated or receiving only non-invasive ventilation
- Patients with enteral feeding contraindication 48 h after admission
- Patients with recent gastrointestinal surgical intervention
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Medical foodenteral formulas with different protein composition | Other | Group A, Group B |
Primary outcome
Calorie and protein target
Time frame: on day 5 days
Differences regarding achieving protein and calorie daily targets in grams per kilogram of body weight (g/kg BW) at day 5 of the intervention period and at day 10 when using enteral nutrition formulas with different protein content
Calorie and protein target
Time frame: on day 10
Differences regarding achieving protein and calorie daily targets in grams per kilogram of body weight (g/kg BW) at day 5 of the intervention period and at day 10 when using enteral nutrition formulas with different protein content
18 secondary outcomes
Ultrasound-guided assessment of gastric residual volume
Time frame: on day 5
Ultrasound-guided assessment of gastric residual volume
Time frame: on day 10
Muscle function
Time frame: 24 hours after extubation
Muscle function
Time frame: 5 days after extubation
Body composition - Fat-free body mass
Time frame: 24 hours after extubation
Body composition - Fat-free body mass
Time frame: 5 days after extubation
Body composition - Total body water
Time frame: 24 hours after extubation
Body composition - Total body water
Time frame: 5 days after extubation
Body composition - Phase angle
Time frame: 24 hours after extubation
Body composition - Phase angle
Time frame: 5 days after extubation
Body composition - ultrasound
Time frame: baseline (on admission/first 24 hours)
Body composition - ultrasound
Time frame: on day 5
Body composition - ultrasound
Time frame: on day 10
Body composition - ultrasound
Time frame: on day 15
Inflammation - CRP
Time frame: on day 5
Inflammation - CRP
Time frame: on day 10
Inflammation - prealbumin
Time frame: on day 5
Inflammation - prealbumin
Time frame: on day 10
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Jul 2024.
- Results publication: PubMed 29895309van Zanten ARH, Petit L, De Waele J, Kieft H, de Wilde J, van Horssen P, Klebach M, Hofman Z. Very high intact-protein formula successfully provides protein intake according to nutritional recommendations in overweight critically ill patients: a double-blind randomized trial. Crit Care. 2018 Jun 12;22(1):156. doi: 10.1186/s13054-018-2070-5.
- Results publication: PubMed 32690175Singer P. Protein metabolism and requirements in the ICU. Clin Nutr ESPEN. 2020 Aug;38:3-8. doi: 10.1016/j.clnesp.2020.03.026. Epub 2020 May 31.
- Results publication: PubMed 34168292Tedeschi-Jockers F, Reinhold S, Hollinger A, Tuchscherer D, Kiss C, Gantner L, Ledergerber K, Zimmermann S, Scheuzger J, Huber J, Siegemund M. A new high protein-to-energy enteral formula with a whey protein hydrolysate to achieve protein targets in critically ill patients: a prospective observational tolerability study. Eur J Clin Nutr. 2022 Mar;76(3):419-427. doi: 10.1038/s41430-021-00956-9. Epub 2021 Jun 24.
- Results publication: PubMed 30077342Berger MM, Reintam-Blaser A, Calder PC, Casaer M, Hiesmayr MJ, Mayer K, Montejo JC, Pichard C, Preiser JC, van Zanten ARH, Bischoff SC, Singer P. Monitoring nutrition in the ICU. Clin Nutr. 2019 Apr;38(2):584-593. doi: 10.1016/j.clnu.2018.07.009. Epub 2018 Jul 20.
- Results publication: PubMed 34596901Yasuda H, Kondo N, Yamamoto R, Asami S, Abe T, Tsujimoto H, Tsujimoto Y, Kataoka Y. Monitoring of gastric residual volume during enteral nutrition. Cochrane Database Syst Rev. 2021 Sep 27;9(9):CD013335. doi: 10.1002/14651858.CD013335.pub2.
- Individual participant dataSharing planned: Yes. Data requests can be submitted by researchers in the field of clinical nutrition starting 9 months after article publication and the data will be made accessible for up to 3 years. Extensions will be considered on a case-by-case basis
Related trials for Metabolism
Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Recruiting
Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults
Hyperglycaemia (Non Diabetic), Prediabetes
Active, not recruiting
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
Common Femoral Artery Stenosis, Calcification; Heart
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Not yet recruitingObservational study
Periodontal Status and Biomarkers in MASLD
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ioana Grintescu, MD, PhD study director
Romanian Society of Enteral and Parenteral Nutrition
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Metabolism and Trauma, run by Romanian Society for Enteral and Parenteral Nutrition at 1 site in Romania.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 22 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Romania. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Ioana Grintescu, MD, PhD (+40722329187, ioana.grintescu@rospen.ro), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Calorie and protein target (time frame: on day 5 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05647135, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2024.